Swiss National Bank Essa Pharma Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.15 - $7.94 $180,180 - $454,168	-57,200 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$6.18 - $14.44 $24,720 - $57,760	4,000 Added 7.52%	57,200 $353,000
Q4 2021 Feb 08, 2022	BUY	$7.8 - $14.38 $31,980 - $58,958	4,100 Added 8.35%	53,200 $755,000
Q3 2021 Nov 08, 2021	BUY	$7.76 - $29.37 $15,520 - $58,740	2,000 Added 4.25%	49,100 $393,000
Q2 2021 Aug 06, 2021	BUY	$24.17 - $34.28 $1.14 Million - $1.61 Million	47,100 New	47,100 $1.35 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $77.6M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.